News of a possible rescue for bond insurer Ambac Financial turns a 129-point loss for the Dow into a 97-point gain in just 45 minutes. Bulls hope the stock market can use the news to rally next week. Genentech wins FDA approval to use its Avastin cancer drug to treat breast cancer.
Read full story
The world’s biggest maker of equipment to direct Internet traffic appears on an MSN Money list of stocks poised for gains. Here are StockScouter’s top picks.
Read full story
Some participants in the Strategy Lab Open aren’t ready to jump on the bank’s bandwagon, but starting to establish a position in the stock seems like a wise move.
Read full story
The very idea of short selling can enrage some investors, but one Strategy Lab player offers an impassioned defense of it.
Read full story
Splitting the debt insurers in two — an idea the banks hate — would be drastic medicine. But for the financial markets, it’s the only relatively fast-acting antidote available.
Read full story
Stocks fall apart as a disappointing manufacturing report from the Philadelphia Federal Reserve Bank overwhelms good news at Cisco Systems and Research In Motion. Gold hits a new high. J.C. Penney reports better-than-expected earnings.
Read full story
The retailer woos shoppers with low prices for food and drugs, hoping they’ll stock up on higher-margin items like clothing. But that’s not happening.
Read full story
The financial system has become dependent on debt and the transfer of risk via convoluted debt instruments, creating a mess that will require hundreds of billions of dollars and global cooperation to fix.
Read full story
Far from unethical, short selling helps keep the markets rational, and it helps punish incompetent management. Here’s a quick primer on how to make the strategy work for your portfolio.
Read full story
Many funds that are listed in 401(k) plans have paid to be included, and it often means 401(k) participants get stuck with mediocre options. Here are three ways to fight the problem.
Read full story
